Evaluating the Effects of Nitroglycerin on Heart Function and Urinary Output in Patients with Acute Heart Failure

PHASE4Not yet recruitingINTERVENTIONAL
Enrollment

21

Participants

Timeline

Start Date

January 1, 2025

Primary Completion Date

June 30, 2025

Study Completion Date

October 31, 2025

Conditions
Acute Heart Failure (AHF)
Interventions
DRUG

Nitroglycerin (NTG)

Infusion of intravenous nitroglycerin beginning at 2 microgram/kg/min (2 ml/hour) and titrated with the aim of a MAP reduction of 20-30%. Infusion rate will not be increased after the first 30 minutes and is limited to 0.1 µg/kg/min to 5 µg/kg/min.

All Listed Sponsors
lead

Copenhagen University Hospital, Hvidovre

OTHER